Pathologic erythrocyte

"Pathologic or abnormal erythrocytes" is not a specific molecular target but rather a descriptive term for **red blood cells (erythrocytes) that display abnormal morphology or function due to underlying diseases**. These abnormalities can include changes in shape, size, structure, or the presence of inclusions within the cells. Common examples are sickle-shaped cells in sickle cell anemia and microcytic/hypochromic cells in thalassemia[3][6]. Other pathologies include nucleated red blood cells seen in severe anemias and megaloblastic changes due to vitamin B12 or folate deficiency[1]. Such abnormalities are typically secondary markers of disease processes rather than direct therapeutic targets. **Key points:** - The term encompasses a wide range of disorders affecting red blood cell morphology and function. - It is not a single molecule/receptor but refers to any RBC with pathological features. - Examples include sickled RBCs (sickle cell anemia), microcytic RBCs (thalassemia), macrocytic/megaloblastic RBCs (vitamin deficiencies), and nucleated forms seen in marrow stress or severe anemia[1][3][6]. - These features serve as diagnostic clues for underlying hematologic diseases but do not represent druggable targets themselves. Because "pathologic or abnormal erythrocytes" does **not refer to a discrete molecular entity**, it should not be considered a canonical therapeutic target. Instead, it describes cellular manifestations resulting from various genetic mutations, metabolic defects, toxic exposures, nutritional deficiencies, or bone marrow disorders[2][3][6].

Other names

Abnormal erythrocyteDiseased red blood cellPathological red blood cellAbnormal RBC